We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 19, 2022

Effect of MS Disease-Modifying Therapies on COVID-19 Vaccination

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
J. Neurol. Neurosurg. Psychiatr. 2022 Sep 01;93(9)986-994, M Etemadifar, H Nouri, M Pitzalis, ML Idda, M Salari, M Baratian, S Mahdavi, AP Abhari, N Sedaghat

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading